Asie · Bourse & Finance · Vietnam Investment Review

Kexing Biopharm displays biosimilar pipeline at CPHI Milan

Publié par Vietnam Investment Review · Vietnam il y a 15 h

Pharmaceutical developer Kexing Biopharm presented its co-developed biosimilar drug pipeline and commercial overseas portfolio at the CPHI Milan 2026 trade exhibition.

Lire l'article complet sur Vietnam Investment Review Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (vir.com.vn)

Kexing Biopharm displays biosimilar pipeline at CPHI Milan

À lire aussi

Malaysia’s OutPerform launches AI avatar for developers

Up 50% in 6 months! Small-cap stock Aye Finance rises today despite weak market - Q2 business update, share price return

MAS introduces enhanced safeguards around public events by financial institutions

Swaraj Engines Q2 Results: Stock jumps 14% after 26% revenue growth, margin expansion

สื่อนอกตีข่าว AirAsia ซุ่มเจรจารัฐบาลมาเลเซียขอซัพพอร์ตทางการเงิน ฉุดราคาหุ้นดิ่งหนัก

Why SC cancelled polls in 50 Punjab wards

Kexing Biopharm displays biosimilar pipeline at CPHI Milan

Partager

À lire aussi

Malaysia’s OutPerform launches AI avatar for developers

Up 50% in 6 months! Small-cap stock Aye Finance rises today despite weak market - Q2 business update, share price return

MAS introduces enhanced safeguards around public events by financial institutions

Swaraj Engines Q2 Results: Stock jumps 14% after 26% revenue growth, margin expansion

สื่อนอกตีข่าว AirAsia ซุ่มเจรจารัฐบาลมาเลเซียขอซัพพอร์ตทางการเงิน ฉุดราคาหุ้นดิ่งหนัก

Why SC cancelled polls in 50 Punjab wards